Ozempic (semaglutide)

Two packages of a fictitious Semaglutide drug used for weight loss

Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s

FDA declared the semaglutide shortage over, marking a win for Novo Nordisk and a big loss for some telehealth companies, at least for now.

Heather Landi Feb 21, 2025 4:30pm

Hims Hers Super Bowl commercial

Hims & Hers' Super Bowl ad turns up the heat on GLP-1 battle

Feb 13, 2025 8:00am

Anti-obesity medication in a tiny shopping cart

New study finds 137M US adults are eligible for GLP-1s

Nov 25, 2024 4:00pm

Healthcare medical graphic image

Payer Roundup—Gov. Newsom vetoes PBM, private equity bills

Sep 30, 2024 2:40pm

dosing pens for antiobesity medication

Telehealth company Ro rolls out GLP-1 supply tracker

May 30, 2024 2:00pm

Wegovy

Costco, Sesame expand into weight loss management

Apr 2, 2024 2:00pm